Exact Mass: 370.1601
Exact Mass Matches: 370.1601
Found 174 metabolites which its exact mass value is equals to given mass value 370.1601
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(S)-1-hydroxy-N-methylcanadine
A quaternary ammonium ion that is (S)-N-methylcanadine in which the hydrogen at position 14 is substituted by a hydroxy group.
thioridazine
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Thioridazine
A phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618) N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AC - Phenothiazines with piperidine structure D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
Apabetalone
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2,7-Di-tert-butyl-9-fluorenylmethyl chloroformate
Methyl (3R,3'S,8'S,10'R)-2-oxospiro[1H-indole-3,12'-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7'-carboxylate
(S)-4-(4-Hydroxyphenyl)-2-butanol 2-O-(6-O-acetyl)-??-D-glucopyranoside
5,5,6-Trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-on|5,5,6-trimethyl-6-(1,2,3-triacetoxy-butyl)-5,6-dihydro-pyran-2-one
Tri-Ac-5, 6-Dihydro-6-(2, 4, 6-trihydroxyheptyl)-2H-pyran-2-one
Benzoyl-(+)-3-Hydroxyestra-1,3,5,7,9-pentaen-17-one
3-O-acetyl-4,5-O(2-methylbutyryl)-and propionylshikimic acid methyl ester|3-O-acetyl-4,5-O<2-methylbutyryl>-and propionylshikimic acid methyl ester
(E)-4-(3,4-dimethoxyphenyl)but-3-en-1-O-beta-D-glucopyranoside|(E)-4-(3,4-Dimethoxyphenyl)but-3-en-1-O-??-D-glucopyranoside
4-hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl beta-D-glucopyranoside|4-Hydroxy-2-[(E)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl ??-D-glucopyranoside
Ala Gly His Ser
Ala Gly Ser His
Ala His Gly Ser
Ala His Ser Gly
Ala Ser Gly His
Ala Ser His Gly
Gly Ala His Ser
Gly Ala Ser His
Gly Gly His Thr
Gly Gly Thr His
Gly His Ala Ser
Gly His Gly Thr
Gly His Ser Ala
Gly His Thr Gly
Gly Ser Ala His
Gly Ser His Ala
Gly Thr Gly His
Gly Thr His Gly
His Ala Gly Ser
His Ala Ser Gly
His Gly Ala Ser
His Gly Gly Thr
His Gly Ser Ala
His Gly Thr Gly
His Ser Ala Gly
His Ser Gly Ala
His Thr Gly Gly
4-hydroxy-3,5-bis(1-methylethyl)phenyl glucuronide
4-hydroxy-2,6-bis(1-methylethyl)phenyl glucuronide
Ser Ala Gly His
Ser Ala His Gly
Ser Gly Ala His
Ser Gly His Ala
Ser His Ala Gly
Ser His Gly Ala
Thr Gly Gly His
Thr Gly His Gly
Thr His Gly Gly
2,3-Dinor-6,15-diketo-13,14-dihydro-20-carboxyl-PGF1a
8-[(1E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-3,9-dihydro-1H-purine-2,6-dione
1-[(1-methylethyl)amino]-4-[(4-methylphenyl)amino]anthraquinone
1,3-Diethyl-8-[(E)-2-(3-hydroxy-4-methoxyphenyl)vinyl]-7-methyl-3 ,7-dihydro-1H-purine-2,6-dione
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-[(4-fluorophenyl)methyl]-N-propyl- (9CI)
1,3-dimethyl-5-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methylidene]-1,3-diazinane-2,4,6-trione
Disilane,1,1,2,2-tetramethyl-1,2-di-1-naphthalenyl-
(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide
3-[(4-Hydroxybenzoyl)amino]azepan-4-YL 4-hydroxybenzoate
RVX-208
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Methyl (3R,3S,8S,10R)-2-oxospiro[1H-indole-3,12-5,11-dioxa-1-azatricyclo[8.4.0.03,8]tetradec-6-ene]-7-carboxylate
5-[4-(2-Furylcarbonyl)piperazino]-5-oxo-3-phenylpentanoic acid
5-(1,3-Benzodioxol-5-ylmethylamino)-2-(4-morpholinyl)benzoic acid methyl ester
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide
2-Amino-7-methyl-5-oxo-4-(2,4,5-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
[(2R)-3-[oxidanyl-[2-(trimethyl-$l^{4}-azanyl)ethoxy]phosphoryl]oxy-2-propanoyloxy-propyl] propanoate
2-Amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile
2-[[[2-[[(4-Methoxyphenyl)-oxomethyl]amino]phenyl]-oxomethyl]amino]-3-methylbutanoic acid
N-[(E)-[2-(1-methylpyridin-1-ium-2-yl)cyclohexylidene]amino]-2,4-dinitroaniline
N-ethyl-N-[[(2S,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
3,4,5-Trihydroxy-6-[1-(4-methoxyphenyl)pentan-3-yloxy]oxane-2-carboxylic acid
N-ethyl-N-[[(2S,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2R,3S,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2R,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2S,3R,4R)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2R,3R,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
N-ethyl-N-[[(2R,3S,4S)-4-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-3-phenyl-2-azetidinyl]methyl]methanesulfonamide
12-(4-ethoxyphenyl)-9,10,11a,12-tetrahydro-8H-benzo[b][4,7]phenanthrolin-11-one
2-[2,3-Di(propanoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-Dihydro-1,1,3,3-tetramethyl-1,3-disilaphenalene-2-spiro-1,2-dihydronaphthalene
2-[(3-Acetyloxy-2-butanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
Nitrocaramiphen (hydrochloride)
Nitrocaramiphen hydrochloride is a selective M1 receptor antagonist (Ki: 5.5 nM). Nitrocaramiphen Hydrochloride inhibits the hyperpolarizing effect of muscarine in the muscle fibers[1][2][3].
(3,4,5-trihydroxy-6-{[4-(4-hydroxyphenyl)butan-2-yl]oxy}oxan-2-yl)methyl acetate
(1r,2r,3s)-1,2-bis(acetyloxy)-1-[(2s)-6-oxo-2,3-dihydropyran-2-yl]heptan-3-yl acetate
6'-acetyl-1,6-dimethoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-2-one
1-hydroxy-5,5,13-trimethyl-4-(3-oxobutanoyl)-4,13-diazatetracyclo[6.6.1.0²,⁶.0¹²,¹⁵]pentadeca-8,10,12(15)-triene-3,14-dione
4a,5,6,7,8-pentahydroxy-2,2-dimethyl-7-(3-methylbut-3-en-1-yn-1-yl)-hexahydro-1-benzopyran-3-yl acetate
4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenylβ-d-glucopyranoside
{"Ingredient_id": "HBIN010450","Ingredient_name": "4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenyl\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C18H26O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10197","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}